Lauren Powell
Family Medicine · Atlanta, GANPI 1275947483
Payments from drug & device makers
Across 65 payments — averaging $246.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$12K
- Zimmer Biomet$2K
- Medtronic$189
- Esperion Therapeutics, Inc.$147
- Amgen$128
- Lilly USA, LLC$123
- plus $656 from 22 others
What the payments were for
- Consulting fees$13,30083%
- Travel & lodging$1,4709%
- Food & beverage$1,2808%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $12,337 |
| Zimmer Biomet | 7 | $2,470 |
| Medtronic | 1 | $189 |
| Esperion Therapeutics, Inc. | 8 | $147 |
| Amgen | 7 | $128 |
| Lilly USA, LLC | 6 | $123 |
| Vital Connect, Inc | 3 | $79 |
| Phathom Pharmaceuticals, Inc. | 4 | $72 |
| Exact Sciences | 3 | $55 |
| Bayer | 3 | $48 |
| Boston Scientific | 1 | $42 |
| Azurity Pharmaceuticals, Inc. | 2 | $39 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $32 |
| Novartis | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Pfizer | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $22 |
| Ionis Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk | 1 | $18 |
| Bausch Health US, LLC | 1 | $18 |
| Lantheus Medical Imaging, Inc. | 1 | $18 |
| Masimo Corporation | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $14 |
| AbbVie | 1 | $14 |
| Linus Health, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$12,300
- Surgical Product Portfolio$1,402
- Hips-None$1,000
- NUVENT$189
How this compares
$16,050 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 28 | $32,412 |
| EliquisApixaban | 18 | $15,154 |
| Rosuvastatin Calcium | 50 | $693 |
| RivastigmineRivastigmine Tartrate | 11 | $683 |
| Estradiol (Once Weekly)Estradiol | 11 | $674 |
| Valsartan | 16 | $598 |
| Levothyroxine Sodium | 54 | $487 |
| Atorvastatin Calcium | 52 | $389 |
| Pantoprazole Sodium | 43 | $358 |
| Amlodipine Besylate | 72 | $325 |
| Omeprazole | 24 | $294 |
| Hydralazine Hcl | 17 | $269 |
| Metoprolol Succinate | 27 | $260 |
| Losartan Potassium | 34 | $210 |
| Simvastatin | 22 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $18 | $32,41228 claims |
| PfizerEliquis | $22 | $15,15418 claims |
| Lilly USA, LLCOlanzapine | $123 | $16912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Atlanta
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Nadia CameronAtlanta$2.1M
- Otis PowellAtlanta$608K
- Thinh NguyenAtlanta$427K
- Patricia MarshAtlanta$175K
- Contessa MetcalfeAtlanta$157K
- Michelle EvansAtlanta$127K
- Mark TannerAtlanta$94K
- Ambar KulshreshthaAtlanta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.